(Q37219253)

19 August 2017

1 reference

title

Mass screening for neuroblastoma in Japan (English)

1 reference

19 August 2017

Mass Screening for Neuroblastoma in Japan (English)

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

12 December 2022

0 references

0 references

1 reference

national health programs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1863547

12 December 2022

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

12 December 2022

author name string

T. Sawada

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1863547

12 December 2022

T. Sugimoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1863547

12 December 2022

H. Kawakatsu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1863547

12 December 2022

T. Matsumura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1863547

12 December 2022

Y. Matsuda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1863547

12 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1863547

12 December 2022

publication date

1 April 1991

1 reference

full work available at URL

19 August 2017

http://www.tandfonline.com/doi/pdf/10.3109/08880019109033437

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

Pediatric Hematology and Oncology

12 December 2022

published in

1 reference

19 August 2017

8

1 reference

19 August 2017

93-109

1 reference

19 August 2017

2

1 reference

Incidence of neuroblastoma in infancy in Japan.

19 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F08880019109033437

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019109033437

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019109033437

Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019109033437

Outcome of 25 neuroblastomas revealed by mass screening in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019109033437

A review of 17 IV-S neuroblastoma patients at the children's hospital of philadelphia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019109033437

Decrease in childhood neuroblastoma death in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019109033437

Screening for neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880019109033437

Incidence of malignant tumors in U.S. children

21 January 2018

3

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

Diagnosis of neuroblastoma by qualitative and quantitative determination of catecholamine metabolites in urine

12 December 2022

7

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group

12 December 2022

9

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

12 December 2022

11

31

2098

Breslow N

1971

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

N-myc oncogene amplification and prognostic factors of neuroblastoma in children

12 December 2022

14

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

12 December 2022

15

47

311

Kaneko Y

1987

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening

12 December 2022

16

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma

12 December 2022

22

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

Liquid chromatographic determination of vanillylmandelic acid and homovanillic acid by a column-switching technique involving direct injection of urine

12 December 2022

23

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

A proposed staging for children with neuroblastoma.Children's cancer study group A

12 December 2022

25

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

Cases of neuroblastoma missed by the mass screening programs

12 December 2022

28

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

Laboratory techniques and neuroblastoma screening

12 December 2022

29

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

A new urinary mass screening system for neuroblastoma in infancy by use of monoclonal antibodies against VMA and HVA

12 December 2022

31

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

Screening for neuroblastoma

12 December 2022

39

1 reference

https://api.crossref.org/works/10.3109/08880019109033437

12 December 2022

Identifiers

1 reference

19 August 2017

1 reference